AVX Pharma   Report issue

For profit Phase 2
Founded: Barcelona Spain (2013)
Status: Acquired by Aerie Pharmaceuticals (2019)

Organization Overview

First Clinical Trial
2017
NCT03162094
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree